Aditya Birla Sun Life Nifty Healthcare ETF
An open ended exchange traded fund tracking Nifty Healthcare TRI
February 2026
| Passive ETFs |  |
 |
 |
 |
An open ended exchange traded fund tracking Nifty Healthcare TRI
February 2026
| Passive ETFs | |
|
|
|
| Investment Objective | |
| The investment objective of the scheme is to provide returns that before expenses, closely correspond to the total returns of securities as represented by Nifty Healthcare TRI, subject to tracking errors. However, the performance of scheme may differ from that of the underlying index due to tracking error.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved. | |
| Fund Category: Exchange Traded Fund (ETF) | |
| Fund Snapshot | |
| Date of Allotment : Oct 20, 2021 | |
| Benchmark: Nifty Healthcare TRI | |
| Fund Manager - Ms. Priya Sridhar Managing the Fund Since: December 31, 2024 Experience in Managing the Fund: 1.2 Years |
|
| Load Structure (as % of NAV) (Incl. for SIP) | |
| Entry Load: | NIL |
| Exit Load: | NIL |
| AUM as on February 27, 2026 (in ₹Crore) | |
| Month End AUM | 54.68 |
| Monthly Average AUM | 66.17 |
| Total Expense Ratio (TER) | |
| Regular | 0.19% |
| Including additional expenses and goods and service tax on management fees. | |
| NAV as on February 27, 2026 | |
| NAV | 15.28 |
| Tracking Error | |
| Tracking Error Regular | 0.03% |
| Other Parameters | |
| Standard Deviation | 16.75% |
| Sharpe Ratio | 1.27 |
| Beta | 1.00 |
| Treynor Ratio | 0.22 |
| Note: Standard Deviation, Sharpe Ratio & Beta are calculated on Annualised basis using 3 years history of monthly returns. Risk Free Rate assumed to be 5.17 % (FBIL Overnight MIBOR as on 27 February, 2026 for calculating Sharpe Ratio |
|
| Minimum Application Amount | |
| For Transactions Directly with the Fund: For Market Makers The Creation Unit size for the Scheme shall be 1,10,000 units and in multiples thereof. For Large Investors Min. application amount shall be Rs. 25 Crores and in multiples of Creation Unit Size. For Transactions on Stock Exchanges Units of ETF scheme can be traded (in lots of 1 Unit) during the trading hours on all trading days on NSE and BSE on which the Units are listed. |
|
| Market Maker | |
|
IRAGE Broking Services LLP Choice Equity Broking Private Ltd. East India Securities Ltd. Kanjalochana Finserv Private Ltd. Parvati Capital Market Private Ltd. |
|
| Top 10 Sectoral Contribution |
 |
| Top 10 Portfolio Holdings |
 |
Sector/Issuer Name |
% of Net AUM |
Equity & Equity Related |
|
Pharmaceuticals & Biotechnology |
78.14% |
• Sun Pharmaceutical Industries Limited |
18.36% |
• Divi's Laboratories Limited |
8.13% |
• Dr. Reddys Laboratories Limited |
7.82% |
• Cipla Limited |
7.57% |
• Lupin Limited |
5.57% |
• Torrent Pharmaceuticals Limited |
4.52% |
• Laurus Labs Limited |
4.17% |
Aurobindo Pharma Limited |
3.41% |
Alkem Laboratories Limited |
3.29% |
Glenmark Pharmaceuticals Limited |
3.21% |
Biocon Limited |
2.78% |
Mankind Pharma Ltd |
2.54% |
Zydus Lifesciences Limited |
2.30% |
IPCA Laboratories Limited |
2.12% |
Abbott India Limited |
1.38% |
Piramal Pharma Ltd |
0.96% |
Healthcare Services |
21.84% |
• Max Healthcare Institute Limited |
8.11% |
• Apollo Hospitals Enterprise Limited |
8.04% |
• Fortis Healthcare Limited |
4.90% |
Syngene International Limited |
0.80% |
Net Cash and Cash Equivalent |
0.02% |
Grand Total |
100.00% |
Miscellaneous includes securities with exposure of less than 0.01%
| Scheme Name | |
| Aditya Birla Sun Life Nifty Healthcare ETF An open ended exchange traded fund tracking Nifty Healthcare TRI |
|
| This product is suitable for investors who are seeking*: | |
|
|
Risk-o-meter  |
Benchmark Risk-o-meter Nifty Healthcare TRI  |
| *Investors should consult their financial advisors if in doubt whether the product is suitable for them. | |